Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
China's CNVD says it found "security backdoor vulnerabilities" in Claude Code that "send sensitive information" like "location and identity to remote servers" (Raffaele Huang/Wall Street Journal)
Raffaele Huang / Wall Street Journal : China's CNVD says it found “security backdoor vulnerabilities” in Claude Code that “send sensi...
-
Sohee Kim / Bloomberg : South Korean authorities are investigating a data leak at e-commerce giant Coupang that exposed ~33.7M accounts; ...
-
Top fintech companies are rushing to tap into this new consumer trend, with several of them offering digital solutions to small merchants. h...
No comments:
Post a Comment